Regulators In Japan Cut Away At New Drug Review Time
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan is posting an overall improvement in shortening the average time it takes regulators to review new drugs, according to a government evaluation committee that rated the operational performance of the Pharmaceuticals and Medical Devices Agency